Insider Transactions in Q4 2021 at Stoke Therapeutics, Inc. (STOK)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 01 2021	Huw M. Nash Chief Business Officer	SELL Open market or private sale	Direct	5,700 -78.07%	$136,800 $24.51 P/Share
Dec 01 2021	Huw M. Nash Chief Business Officer	BUY Exercise of conversion of derivative security	Direct	5,700 +50.0%	$11,400 $2.19 P/Share
Nov 03 2021	Huw M. Nash Chief Business Officer	SELL Open market or private sale	Direct	1,900 -100.0%	$47,500 $25.0 P/Share
Nov 03 2021	Huw M. Nash Chief Business Officer	BUY Exercise of conversion of derivative security	Direct	1,900 +50.0%	$3,800 $2.19 P/Share
Nov 01 2021	Huw M. Nash Chief Business Officer	SELL Open market or private sale	Direct	3,800 -78.82%	$87,400 $23.57 P/Share
Nov 01 2021	Huw M. Nash Chief Business Officer	BUY Exercise of conversion of derivative security	Direct	3,800 +50.0%	$7,600 $2.19 P/Share
Oct 01 2021	Huw M. Nash Chief Business Officer	SELL Open market or private sale	Direct	5,700 -100.0%	$136,800 $24.83 P/Share
Oct 01 2021	Huw M. Nash Chief Business Officer	BUY Exercise of conversion of derivative security	Direct	5,700 +50.0%	$11,400 $2.19 P/Share

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Value

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

Operation

Value

Type

Receive news related to Stoke Therapeutics, Inc.